Efficacy and Safety of Prasugrel vs Clopidogrel in Thrombotic Stroke Patients With Risk Factors for Ischemic Stroke Recurrence: A Double-blind, Phase III Study (PRASTRO-III)

Aim: To examine the efficacy and safety of prasugrel vs clopidogrel in thrombotic stroke patients at risk of ischemic stroke. Methods: This multicenter, active-controlled, randomized, double-blind, double-dummy, parallel group study enrolled thrombotic stroke patients aged ≥ 50 years at risk of isch...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitazono, Takanari, Kamouchi, Masahiro, Matsumaru, Yuji, Nakamura, Masato, Umemura, Kazuo, Matsuo, Hajime, Koyama, Nobuyuki, Tsutsumi, Junko, Kimura, Kazumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981351/
https://www.ncbi.nlm.nih.gov/pubmed/35599000
http://dx.doi.org/10.5551/jat.63473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981351/
https://www.ncbi.nlm.nih.gov/pubmed/35599000
http://dx.doi.org/10.5551/jat.63473

Ejemplares similares